These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22343002)

  • 1. Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways.
    Cimini A; D'Angelo B; Das S; Gentile R; Benedetti E; Singh V; Monaco AM; Santucci S; Seal S
    Acta Biomater; 2012 Jul; 8(6):2056-67. PubMed ID: 22343002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-situ growth of CeO
    Chi M; Liu J; Li L; Zhang Y; Xie M
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113887. PubMed ID: 38581835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles.
    Singh S; Kumar A; Karakoti A; Seal S; Self WT
    Mol Biosyst; 2010 Oct; 6(10):1813-20. PubMed ID: 20697616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of partial EMT-induced tumour cell growth by cerium valence states of extracellular ceria nanoparticles for anticancer treatment.
    Naganuma T
    Colloids Surf B Biointerfaces; 2024 Apr; 236():113794. PubMed ID: 38382224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impressive Anti-Inflammatory Activity of Cerium Oxide Nanoparticles: More than Redox?
    Corsi F; Deidda Tarquini G; Urbani M; Bejarano I; Traversa E; Ghibelli L
    Nanomaterials (Basel); 2023 Oct; 13(20):. PubMed ID: 37887953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease.
    Esteves M; Cristóvão AC; Saraiva T; Rocha SM; Baltazar G; Ferreira L; Bernardino L
    Front Aging Neurosci; 2015; 7():20. PubMed ID: 25798108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain.
    Heckman KL; DeCoteau W; Estevez A; Reed KJ; Costanzo W; Sanford D; Leiter JC; Clauss J; Knapp K; Gomez C; Mullen P; Rathbun E; Prime K; Marini J; Patchefsky J; Patchefsky AS; Hailstone RK; Erlichman JS
    ACS Nano; 2013 Dec; 7(12):10582-96. PubMed ID: 24266731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.
    Nayab DE; Din FU; Ali H; Kausar WA; Urooj S; Zafar M; Khan I; Shabbir K; Khan GM
    J Nanobiotechnology; 2023 Dec; 21(1):477. PubMed ID: 38087359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Cerium Oxide Nanoparticles in Non-Alcoholic Fatty Liver Disease Evolution Using In Vivo and In Vitro Studies: A Systematic Review.
    Sandoval C; Reyes C; Rosas P; Godoy K; Souza-Mello V; Farías J
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated nanoceria: A versatile nanomaterial for noninvasive treatment of retinal diseases.
    Alrobaian M
    Saudi Pharm J; 2023 Oct; 31(10):101761. PubMed ID: 37705880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoceria as Safe Contrast Agents for X-ray CT Imaging.
    García A; Cámara JA; Boullosa AM; Gustà MF; Mondragón L; Schwartz S; Casals E; Abasolo I; Bastús NG; Puntes V
    Nanomaterials (Basel); 2023 Jul; 13(15):. PubMed ID: 37570527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomaterials-based anti-inflammatory treatment strategies for Alzheimer's disease.
    Chu J; Zhang W; Liu Y; Gong B; Ji W; Yin T; Gao C; Liangwen D; Hao M; Chen C; Zhuang J; Gao J; Yin Y
    Neural Regen Res; 2024 Jan; 19(1):100-115. PubMed ID: 37488851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germanium Dioxide Nanoparticles Mitigate Biochemical and Molecular Changes Characterizing Alzheimer's Disease in Rats.
    Abdel Gaber SA; Hamza AH; Tantawy MA; Toraih EA; Ahmed HH
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, Characterization and Multiple Biological Properties of Peptide-Modified Cerium Oxide Nanoparticles.
    Wang M; He H; Liu D; Ma M; Zhang Y
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system injury meets nanoceria: opportunities and challenges.
    Yang W; Zhang M; He J; Gong M; Sun J; Yang X
    Regen Biomater; 2022; 9():rbac037. PubMed ID: 35784095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of therapeutic potential of cerium oxide nanoparticles in Alzheimer's disease using transgenic
    Sundararajan V; Venkatasubbu GD; Sheik Mohideen S
    3 Biotech; 2021 Apr; 11(4):159. PubMed ID: 33758737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design and Biological Application of Antioxidant Nanozymes.
    Tian R; Xu J; Luo Q; Hou C; Liu J
    Front Chem; 2020; 8():831. PubMed ID: 33644000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.
    Zorkina Y; Abramova O; Ushakova V; Morozova A; Zubkov E; Valikhov M; Melnikov P; Majouga A; Chekhonin V
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview on recent
    Stephen Inbaraj B; Chen BH
    Asian J Pharm Sci; 2020 Sep; 15(5):558-575. PubMed ID: 33193860
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.